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Huntington’s disease (HD) is a fatal, dominantly inherited, neurodegenerative disorder
due to a pathological expansion of the CAG repeat in the coding region of the
HTT gene. In the quest for understanding the molecular basis of neurodegeneration,
we have previously demonstrated that the prolyl isomerase Pin1 plays a crucial
role in mediating p53-dependent apoptosis triggered by mutant huntingtin (mHtt)
in vitro. To assess the effects of the lack of Pin1 in vivo, we have bred Pin1
knock-out mice with HdhQ111 knock-in mice, a genetically precise model of HD.
We show that Pin1 genetic ablation modifies a portion of HdhQ111 phenotypes
in a time-dependent fashion. As an early event, Pin1 activity reduces the DNA
damage response (DDR). In midlife mice, by taking advantage of next-generation
sequencing technology, we show that Pin1 activity modulates a portion of the
alterations triggered by mHtt, extending the role of Pin1 to two additional HdhQ111
phenotypes: the unbalance in the “synthesis/concentration of hormones”, as well
as the alteration of “Wnt/β-catenin signaling”. In aging animals, Pin1 significantly
increases the number of mHtt-positive nuclear inclusions while it reduces gliosis.
In summary, this work provides further support for a role of Pin1 in HD
pathogenesis.
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INTRODUCTION
Huntington’s disease (HD) is a dominantly inherited neurodegenerative disorder, characterized by
motor impairment and cognitive decline. Neuropathologically, HD presents selective neuronal loss
in the striatum associated to astrocytic gliosis that increases with disease progression (Vonsattel
et al., 1985). In the later stage of the disease, pathologic alterations have been described in other
brain regions, including cerebral cortex, thalamus, and subthalamic nucleus (Vonsattel and
DiFiglia, 1998).
The HD mutation alters a polymorphic CAG trinucleotide repeat in the first exon of
HTT, the gene encoding for huntingtin (The Huntington’s Disease Collaborative Research
Group, 1993). The number of CAG repeats varies between 6 and 35 units on normal
chromosomes, whereas on HD chromosomes the repeat is expanded above the pathological
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threshold of 36 CAGs. This leads to the synthesis of a mutant
protein containing an expanded polyglutamine tract at the
N-terminus that confers to the protein the tendency to aggregate.
Neuronal intranuclear inclusions (NIIs) and neuropil aggregates
that stain positive for huntingtin are a clear histopathological
marker of the disease (DiFiglia et al., 1997; Gutekunst et al.,
1999).
Mutant huntingtin (mHtt) triggers a large plethora of
cellular dysfunctions, as reviewed by Zuccato et al. (2010)
and Labbadia and Morimoto (2013). Among them, there is
transcriptional deregulation as well as induction of nucleolar
and endoplasmic reticulum stress (Sugars and Rubinsztein, 2003;
Cha, 2007; Carnemolla et al., 2009; Lee et al., 2014). mHtt
expression is also associated with extensive Deoxyribonucleic
acid (DNA) lesions and the activation of the ATM/ATR
DNA damage response (DDR) pathway with consequent
phosphorylation of H2AX at the damaged sites and stabilization
of p53, which in turn mediates mitochondrial dysfunction and
cytotoxicity (Bae et al., 2005; Anne et al., 2007; Illuzzi et al.,
2009).
Recently, a genome-scale RNAi screen to search for pathways
interfering with mHtt toxicity has identified peptidyl-prolyl
cis/trans isomerase NIMA-interacting 1 (Pin1; Miller et al.,
2012). siRNA reduction of Pin1 was found to decrease caspase-
3 activation induced by the expression of a truncated N-
terminal fragment of mHtt in HEK293T cells. Similarly, in
mutant STHdhQ111 striatal cell line, knock-down of Pin1 reduced
caspase activation triggered by serum deprivation to a level
comparable to controls. Furthermore, the motor performance
defect in a Drosophila HD model was significantly rescued
upon decreased expression of the Pin1 homolog dodo (Miller
et al., 2012). Intriguingly, juglone, a potent Pin1 inhibitor, was
previously found to reverse the abnormal cellular localization
of full-length mHtt in STHdhQ111 striatal cells (Wang et al.,
2005).
Phosphorylation—dependent prolyl isomerization triggered
by Pin1 represents an essential mechanism in modulating
many cellular processes. Pin1 is highly expressed in the
brain where it plays a critical role in healthy aging and
prevention of age-related neurodegeneration (Liou et al.,
2003; Sorrentino et al., 2014). Detailed molecular analyses
in mice and cells led to the findings that in Alzheimer’s
disease Pin1 regulates amyloid precursor protein (APP)
processing and amyloid-beta production (Pastorino et al., 2006)
while it is required for Tau dephosphorylation and correct
neurofibrillary organization (Liou et al., 2003). Furthermore,
in Parkinson’s disease Pin1 facilitates formation of alpha-
synuclein inclusions by regulating its binding partner synphilin
(Ryo et al., 2006).
We have previously shown that in cell culture and in mouse
brain Pin1 activity is required for p53 activation in response
to mHtt (Grison et al., 2011). In HD cellular models and
human post-mortem brains, p53 is phosphorylated on Ser46, a
modification that triggers the interaction with Pin1 and activates
p53 apoptotic functions. As a consequence, the genetic ablation
of Pin1 prevents the expression of p53 apoptotic target genes in
the striatum of HdhQ111 mice (Grison et al., 2011).
HdhQ111 knock-in mice (White et al., 1997) display molecular
and behavioral phenotypes that recapitulate, in a time-dependent
fashion, many features of the human disease (Fossale et al.,
2002; Wheeler et al., 2002; Gines et al., 2003; Lloret et al.,
2006; Lynch et al., 2007; Carnemolla et al., 2009; Giralt et al.,
2012; Hölter et al., 2013). In the first months of life, initial
molecular changes (here referred to as ‘‘early phenotypes’’)
include the activation of DDR and the induction of ribosome
biogenesis regulator 1 (Rrs1) expression, a nucleolar protein
involved in rRNA biogenesis and endoplasmic reticulum stress.
At a later age (‘‘intermediate phenotypes’’), mHtt alters the
expression of several pathways and genes with a plethora of
different functions. In aging animals (‘‘late phenotypes’’), NIIs
decorate the large majority of striatal neurons while gliosis
infiltrate the nervous system as evidenced in human post-
mortem brains.
Since Pin1 activity is involved in DDR and formation
of protein aggregates, here we have taken advantage of
HdhQ111 mice in a Pin1 knock-out genetic background
(Grison et al., 2011) to prove that Pin1 modulates multiple
HdhQ111 phenotypes throughout the lifespan of the
rodent.
MATERIALS AND METHODS
Mice Strain
Heterozygous (HdhQ7/Q111) knock-in mice in C57BL/6
background (Lloret et al., 2006) were provided byM.MacDonald
(Massachusetts General Hospital, Boston, MA, USA). Pin1
knock-out mice in C57BL/6 background (Atchison et al.,
2003) were provided by A. Means (Duke University, Durham,
NC, USA). HdhQ7/Q111 and Pin1WT/KO mice were crossed
to generate double heterozygous mice. These mice were
then crossed to generate littermates of different genotypes.
Mice used in this study were HdhQ7/Q7, HdhQ111/Q111 (3.5
and 12 months) or HdhQ7/Q111 (24 months) either wild-type
(Pin1WT/WT) or homozygous knock-out (Pin1KO/KO) for Pin1.
Genotyping for both loci was performed by PCR on tail DNA
as described previously (White et al., 1997; Atchison et al.,
2003). Mice were balanced with respect to gender except for
the gene expression profiling experiments where only female
mice were used. HdhQ111:Pin1KO mice appear healthy, do
not display any gross physical or behavioral abnormalities
and have a normal life span. Animal care, handling and
subsequent procedures were performed in accordance with
the European Community Council Directive of November 24,
1986 (86/609EEC) and following SISSA Ethical Committee
permissions.
RNA Isolation and Real Time PCR
Total RNA was extracted from mouse striata using TRIzolr
reagent (Invitrogen) according to manufacturer’s instructions.
RNA was quantified (Qubit, Life Technologies) and quality was
monitored using a Bioanalyzer (Agilent Technologies).
Rrs1 RT-qPCR was performed with CFX96 TouchTM Real-
Time PCR instrument (Bio-Rad), using the iQ SYBR Green
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Supermix (Bio-Rad) as previously described (Carnemolla et al.,
2009). Normalized expression values were calculated using
β-actin as the endogenous control.
RNA-Seq and Data Processing
RNAseq was performed by IGA Technology Services, Udine,
Italy. Libraries were prepared using the TruSeq RNA Kit
(Illumina) and sequenced with aHiSeq2000 sequencer (Illumina)
to generate 50bp single reads. For each library, more than 40
million of reads were obtained.
Quality control of RNA-seq reads was performed using
FastQC1. Genome mapping was carried out with STAR
aligner (v2.3.0, ENSEMBL.mus_musculus.release-75 as
reference genome, Dobin et al., 2013). Mapped reads were
counted with HTSeq (v0.6,2 Anders et al., 2015). Differential
gene expression analysis was performed using the gene
raw counts, within the R/Bioconductor edgeR package
(Robinson et al., 2010). The bioinformatic pipeline was
customized to: (1) estimate the dispersion parameter for each
library using the biological group dispersion; (2) identify
differentially expressed genes between the animal models
(HdhQ111 vs. HdhQ7 in Pin1WT background, Pin1WT vs. Pin1KO
in HdhQ111 background); (3) consider log2 (fold-change)
≥0.7 as threshold; and (4) adjust the P-value for multiple
testing using the Benjamini-Hochberg correction with a
false discovery rate (FDR) ≤0.05. Functional annotation,
category and pathway analysis of the differential gene lists
was carried out using the R/Bioconductor ClusterProfiler
(Yu et al., 2012) package and Ingenuity Pathway Analysis
tool (IPA; QIAGEN Silicon Valley, Redwood City, CA,
USA3). For ClusterProfiler we calculated the enrichment
value (p < 0.05, additional parameters as standard)
for biological process, molecular function and cellular
component. For IPA, transcripts were associated with biological
functions/transcriptional regulators in the Ingenuity Knowledge
Base. Right-tailed Fisher’s exact test was used to calculate
a p-value determining the probability that each biological
function/transcriptional regulator assigned to that data set
is due to chance alone. All sequencing data were submitted
to the Gene Expression Omnibus (GEO; accession number
GSE64478).
Western Blot
Total protein lysates from mouse striatum were extracted
using TRIzolr reagent (Invitrogen) according to manufacturer’s
instructions, after RNA extraction. Ten microgram (10 µg)
of protein lysates were analyzed by western blot. Primary
antibodies were: anti γ-H2AX (1:1000, Millipore), anti-β-actin
(1:5000, A1978, Sigma) and anti-Pin1 (1:2000, G-8, Santa Cruz
Biotech).
Relative quantification of protein bands from western blot
scans was performed with ImageJ Software.
1www.bioinformatics.babraham.ac.uk/projects/fastqc/
2http://www-huber.embl.de/users/anders/HTSeq
3www.ingenuity.com.
Immunohistochemistry
Animals were transcardially perfused with 4% paraformaldehyde
in Phosphate-Buffered Saline (PBS) solution (pH 7.4). The brain
was rapidly dissected out, post-fixed o/n at 4◦C in the same
fixative and then kept at 4◦C in 30% sucrose/PBS until it
had sunk. Using a vibratome (Vibratome 1000 Plus Sectioning
System, St Louis, MO, USA), coronal sections of 40 µm
thickness were cut throughout the striatum (−3 mm to +3 mm
from Bregma) and every 10th sections samples were processed
for immunohistochemistry. To block endogenous peroxidase
free-floating sections were treated for 10 min with Tris-Buffered
Saline (TBS) solution containing 10% methanol and 3% H2O2.
After washing in TBS, sections were incubated for 1 h in blocking
solution (1% BSA, 10% FCS, 1% fish gelatin) and then o/n at
4◦C with the primary antibodies in TBS containing 1% BSA,
0.3% Triton X-100 and 0.1% fish gelatin. Sections were washed
and incubated for 1 h with secondary anti-mouse Alexa-488
conjugated antibody (1:2000). Images were captured using a
Leica TCS SP2 confocal microscope.
Primary antibodies were: EM48 anti-huntingtin (1:100,
MAB5374, Chemicon), anti-glial fibrillary acidic protein
(GFAP; 1:1000, G6171, Sigma) and anti-γH2AX (1:500, 05–636,
Millipore).
Huntingtin Inclusions and GFAP
Fluorescence Quantification
Quantification of nuclear inclusions in 24 month old mice
was performed as follow. Three serial coronal sections
(0.78–0 mm from bregma) were chosen for each mouse.
In each section two areas of the striatum (375 µm2
each), one dorsal and one ventral, were identified using
a 40× oil objective. Confocal photomicrograhs of six
Z-sections (5 µm) of the selected areas were taken and
the total number of nuclear inclusions was counted in the
Z-stack images using eCELLence Software (Glance Vision
Technologies, Trieste, Italy). The total number of inclusions
was counted per mouse and the arithmetic mean of four
mice for each genotype was calculated and expressed as
number of NI/100 µm2. The same method was applied
to evaluate the number of inclusions in piriform cortex
and olfactory tubercles regions (40× objective, one area
of 375 µm2 per section). GFAP fluorescence intensity
was evaluated in the same striatal areas described above
with a 20× objective (one area of 750 µm2 per section,
three sections per mice, four mice per genotype) using the
Leica Confocal Software Histogram Quantification Tool.
Pixel mean fluorescence intensity (expressed in arbitrary
units) of the selected area was normalized to background
fluorescence (region without cells). A paired two-tailed
Student’s t-test (Microsoft Excel Software) was used for
statistical analysis. Values with p < 0.05 were considered
significant.
Statistical Analysis
Depending on the number of groups within the data set, data
were analyzed using either the Student’s t-test (two groups) or
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one-way ANOVAwith Tukey’s HSD post hoc test (three groups).
The p values < 0.05 were considered statistically significant.
Calculated means and standard errors were plotted using the
graph tool of Microsoft Excel.
RESULTS
Effects of Loss of Pin1 on HdhQ111 “Early
Phenotypes”
A number of alterations have been identified so far as
early events in HdhQ111 mice. Among them we have studied
the effects of Pin1 activity on DDR and Rrs1 induction.
These phenotypes were assessed by analyzing homozygous
HdhQ111 mice that were either wild-type (HdhQ111:Pin1WT)
or knock-out for Pin1 (HdhQ111:Pin1KO) at 3.5 months
of age.
Pin1 Modulates DDR Induced by mHtt in Mouse
Striatum
Many studies in cell lines, transgenic mouse models and
HD post-mortem brains have shown that mHtt can
induce DNA damage (Giuliano et al., 2003; Anne et al.,
2007; Stack et al., 2008; Illuzzi et al., 2009). Importantly,
Pin1 has also been linked to DDR, particularly in the
regulation of double strand break repair (Steger et al.,
2013). Therefore, we compared the level of DNA damage
in HdhQ111:Pin1WT and HdhQ111:Pin1KO mice. For this
purpose we assayed the DNA damage marker γH2AX by
immunofluorescence and western blot analysis (Figures 1A–C).
Phosphorylation of the histone variant H2AX, forming
γH2AX-labeled foci, represents the earliest visible response
to the induction of DNA double-strand breaks. As expected,
protein extracts from striatum of HdhQ111 mice showed
high levels of phosphorylated H2AX compared to wild-
type littermates, supporting the presence of DNA damage
in neurons of 3.5 month old HdhQ111 mice (Figure 1A).
Interestingly, the lack of Pin1 expression decreased the
intensity of γH2AX signal (Figures 1B–C). Western blot
quantification of γH2AX relative to β-actin indicated that, in
absence of Pin1, the expression of phosphorylated H2AX is
significantly reduced by about 20% (Figure 1B). These results
suggest that Pin1 modulates striatal DNA damage induced
by mHtt.
Rrs1 Induction by mHtt is not Modulated by Pin1
We have previously demonstrated that Rrs1 mRNA expression
is increased in post-mortem brain of HD patients (Fossale
et al., 2002). Rrs1 is a nucleolar protein involved in rRNA
biogenesis and a component of the endoplasmic reticulum stress
response (Carnemolla et al., 2009). Its induction is one of the
earliest events occurring inHdhQ111 mice that persist throughout
the life span of the rodent (Fossale et al., 2002; Carnemolla
et al., 2009). To test whether Pin1 could modulate Rrs1
expression in HdhQ111 mice, we compared the expression level
of Rrs1 by RT-qPCR in HdhQ111:Pin1WT and HdhQ111:Pin1KO
at 3.5 months of age. As expected, Rrs1 is induced by 1.6
fold in HdhQ111 compared to wild type littermates in a Pin1
wild type background (Figure 1D). No significant difference
was detectable between HdhQ111:Pin1WT and HdhQ111:Pin1KO
mice.
In summary these results suggest that Pin1 may modify some
but not all of the ‘‘early phenotypes’’ selected for assessment in
HdhQ111 mice.
Effects of Lack of Pin1 on HdhQ111
“Intermediate Phenotypes”
A plethora of genes and pathways are known to be altered in the
striatum of midlife HD mouse models. To estimate the portion
of HdhQ111 ‘‘intermediate phenotypes’’ that requires a functional
Pin1, we decided to carry out an unbiased transcriptome-wide
approach by taking advantage of next generation sequencing
technology.
We thus carried out a search for differentially expressed
transcripts in the following genotypes: HdhQ7/Q7:Pin1WT/WT ,
HdhQ111/Q111:Pin1WT/WT , HdhQ7/Q7:Pin1KO/KO and
HdhQ111/Q111:Pin1KO/KO. RNAs from the striatum of three
mice of 12 months of age were purified for each genotype
to carry out gene expression profiling with next-generation
sequencing technology with the MiSeq Illumina platform and
analyzed following standard best practices.
First we compared HdhQ111 with HdhQ7 mice on a Pin1
wild-type background to describe differences in gene expression
triggered by mHtt. Overall we obtained a list of 621 genes
significantly altered by mHtt (Figure 2A, Supplementary
Table T1). We then asked whether lack of a functional Pin1
modifies the expression pattern of HdhQ111 mice identifying
145 genes as differentially regulated between Pin1 wild-type and
knock-out mice on a mHtt background.
Interestingly, 44% of them (64/145, overlap p-value = 10−64)
were commonly targeted by mHtt in a wild-type genotype
for Pin1 suggesting that Pin1 may act on pathways shared
with mHtt. In the same stage and tissue, loss of Pin1 in a
wild-type Htt background was altering the expression of 213
genes.
In summary, 29 genes (out of 64) were differentially regulated
in all three comparisons while 35 of the genes altered in HdhQ111
mice were changed by loss of Pin1 activity exclusively inmHtt but
not in HdhQ7 mice (Figure 2A, Supplementary Tables T1, T2).
We then analyzed the enrichment for Gene Ontology
biological terms in the three differentially expressed gene
lists using ClusterProfiler (Supplementary Table T3). While
mHtt changed the expression of genes associated to 1493
biological terms, the effects of Pin1 loss on mHtt were
described with 194 terms. Importantly, 156 of them were
common in the two lists (Figure 2B). Loss of Pin1 in
a wild-type Htt background was involving 242 biological
terms.
In summary, loss of Pin1 in HdhQ111 background affected
only 10% (156/1493) of the biological terms targeted by mHtt
alone. These represented 80% (156/194) of all the biological
terms associated to loss of Pin1 in mHtt background. Seventy
five (out of 156) were common among all three comparisons
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FIGURE 1 | Consequences of Pin1 depletion on HdhQ111 “early phenotypes”. (A–C) Pin1 modulates mutant huntingtin (mHtt)-induced DNA damage.
(A) Representative western blot showing γH2AX protein levels in lysates from striatum of homozygous HdhQ111 and HdhQ7 mice at 3.5 months of age. β-actin
antibody was used as control of sample loading. (B) Representative western blot showing comparison of γH2AX protein levels in striatum of HdhQ111 mice on
wild-type (n = 6) or knock-out (n = 6) Pin1 genetic backgrounds at 3.5 months of age. β-actin was used as a loading control. The histogram on the right shows
relative quantifications of γH2AX signals between the two genotypes. Histogram bars represent mean ± standard error (∗Two tail paired t-test p < 0.05).
(C) Comparison of immunofluorescence staining of γH2AX foci in coronal brain sections from striatum of 3.5 months mice of the indicated genotypes. The nuclear
staining with 4′,6-diamidino-2-phenylindole (DAPI) is shown in blue. Scale bar, 30 µm. Inset shows γH2AX foci at higher magnification. Scale bar, 10 µm. (D) Rrs1
mRNA induction is not modulated by Pin1. RT-qPCR analysis was performed to detect levels of Rrs1 relative to β-actin mRNAs in striatum of HdhQ7 (n = 6) and
homozygous HdhQ111 mice on wild type (n = 6) or knock out (n = 6) Pin1 genetic background at 3.5 months of age. A significant increase of Rrs1 mRNA is found in
HdhQ111:Pin1WT and HdhQ111:Pin1KO mice compared to HdhQ7:Pin1WT mice. No significant difference in the level of Rrs1 mRNA is detected in HdhQ111:Pin1WT
compared to HdhQ111:Pin1KO mice. Histogram bars represent mean ± standard error (∗∗∗one-way ANOVA Tukey HSD post hoc test, p < 0.001).
and 81 were part of a Pin1-dependent gene expression
pattern exclusively triggered by mHtt (Supplementary
Table T4).
Since this type of analysis does not allow the prediction
of the activation/inhibition status for each biological term,
we took advantage of the IPA Downstream Effects Analysis
tool to identify biological functions that are expected to
increase or decrease according to gene expression changes.
By comparing the gene lists in Supplementary Table T1 we
observed enriched biological functions in opposite directions
(activation/inhibition) when induced by mHtt on a Pin1 wild-
type background compared to loss of Pin1 in a mHtt background
(Pearson’s Correlation = 0.69, p-value = 10−10; Figure 2C).
Among them, the biological functions ‘‘quantity/synthesis of
steroid’’ and ‘‘synthesis/concentration of hormone’’ triggered
by mHtt were reverted by loss of Pin1. These two pathways
were not significantly affected in Pin1 knock-out mice in
a wild-type Htt background. Loss of Pin1 in HdhQ111 mice
was able to counteract changes in ‘‘Wnt/β-catenin signaling’’,
‘‘PCP pathway’’ and ‘‘Role of Wnt/GSK-3β signaling in the
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FIGURE 2 | Transcriptome functional analysis in the striatum of midlife mice suggests that loss of Pin1 reverts biological functions altered by mutant
huntingtin (mHtt). (A) Venn diagram showing the overlap of differentially expressed gene lists among the comparisons of the indicated genotypes (Supplementary
Table T2). (B) Venn diagram showing the overlap of the biological terms among the comparisons of the indicated genotypes (Supplementary Table T4). (C) Table
showing the predicted activation and repression of different biological terms using Ingenuity Pathway Analysis (IPA). Activation Z-score and –log (p-value) are shown.
Activation Z-score makes predictions about potential regulators by using information about the direction of gene regulation. Red or blue box correspond to activation
or repression prediction of the biological pathways.
pathogenesis of influenza’’ as triggered by mHtt. These pathways
were also altered in Pin1 knock-out mice that were wild-type
for Htt (Figure 2C). In Supplementary Table T5 gene lists
associated to each pathways and biological functions are shown.
Effects of Lack of Pin1 on HdhQ111 “Late
Phenotypes”
Aging HdhQ111 mice recapitulate two neuropathological
hallmarks of human HD post-mortem brains: the presence of
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NIIs in striatal neurons and the occurrence of massive gliosis.
Therefore we investigate these phenotypes in heterozygous
HdhQ111 mice either wild-type (HdhQ111:Pin1WT) or knock-out
(HdhQ111:Pin1KO) for Pin1 at 24 months of age.
Mutant Huntingtin NIIs in Mouse Striatum are
Increased in the Absence of Pin1
NIIs of amino-terminal fragments of mHtt are a well-known
histopathological marker of HD (DiFiglia et al., 1997; Gutekunst
et al., 1999). Pin1 has been previously found to modulate
protein aggregate formation in other neurodegenerative
diseases (Lu et al., 1999; Ryo et al., 2006; Kesavapany et al.,
2007). Coronal sections of mouse brains were immunostained
with EM48 antibody that selectively labels mHtt. As shown
in Figure 3A, mHtt was detectable in striatum of both
genotypes as nuclear inclusions. Interestingly, the number
of NIIs was significantly increased in HdhQ111 mice lacking
Pin1 compared to HdhQ111:Pin1WT mice (Figure 3B). At
24 months of age, NIIs were also detectable in brain area
other than the striatum including the olfactory tuberculus
and piriform cortex (Supplementary Figure S1). However,
no differences were detected in these regions between
HdhQ111:Pin1WT and HdhQ111:Pin1KO mice (Figure 3C). In
summary, Pin1 loss increases NIIs formation selectively in the
striatum proving that Pin1 plays a role in NIIs formation
in vivo.
Astrocytic Gliosis in Striatum of HdhQ111 Mice is
Reduced in the Absence of Pin1
Astrocytic gliosis, an important hallmark of HD pathogenesis,
is recapitulated in aged HdhQ111 mice (Wheeler et al., 2002).
To assess whether Pin1 may modulate the proliferation of
astrocytes in HdhQ111 mice, we carried out immunofluorescence
analysis using the GFAP antibody in mouse brain sections.
First we compared HdhQ111 mice with HdhQ7 wild-type
littermates, both on a Pin1 wild-type background, at 24 months
of age. As expected, a fibrillary network intensely stained by
GFAP antibody is shown in the striatum of mutant knock-in
mice, but not in their wild-type counterpart (Figure 4A).
Interestingly, GFAP immunoreactivity was markedly reduced in
striatum of HdhQ111:Pin1KO mice compared to littermates
HdhQ111 expressing Pin1 (Figure 4B). To better assess
these differences we quantified the fluorescence intensity
of GFAP. As shown in Figure 4C we found a significant
reduction of GFAP immunoreactivity in HhdQ111 mice
lacking Pin1.
These results suggest that Pin1 is involved in astrocytosis
triggered by mHtt.
DISCUSSION
In the quest for understanding HD pathogenesis, the use of
animal models has been instrumental in evaluating the impact
of manipulating the expression of a single gene or the activity of
entire pathways on the hallmarks of disease progression.
HdhQ111 mice present several advantages. This genetically
precise HD mouse model shows different molecular phenotypes
FIGURE 3 | The number of mHtt intranuclear inclusions in aged mice is
modulated by Pin1 in striatum but not in olfactory tubercle and
piriform cortex. (A) Representative confocal images of EM48 positive
neuronal intranuclear inclusions (NIIs) from striatal sections of 24 months mice
(genotypes as indicated). The nuclear staining with 4′, 6-diamidino-
2-phenylindole (DAPI) is shown in blue. Scale bar, 20 µm. (B) The number of
NIIs in striatum of heterozygous HdhQ111 mice lacking of Pin1 is significantly
increased compared to HdhQ111:Pin1WT mice. The histogram shows
quantification of EM48-positive inclusions in striatum of HdhQ111 mice
(Continued)
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FIGURE 3 | Continued
on wild-type or knock-out Pin1 genotype. Histogram bars represent
mean ± standard error of the number of inclusions per 100 µm2, three
sections per mouse and four mice per genotype. (∗Two tail paired t-test
p < 0.05). (C) Histograms showing quantification of EM48-positive inclusions
in olfactory tubercle (left) and piriform cortex (right) of HdhQ111 mice on
wild-type (n = 4) or knock-out (n = 4) Pin1 genotype at 24 months of age. No
significant differences are observed in these brain regions between the two
genotypes.
at different ages. The main interest resides in the identification of
early alterations (‘‘early phenotypes’’) that cannot be studied in
human tissues. ‘‘Late phenotypes’’ such as the formation of NIIs
and the presence of massive gliosis mimic neuro-pathological
data in human post-mortem brains.
By breedingHdhQ111 knock-in mice with a knock-out line for
Pin1, we assessed the effects of the lack of a functional Pin1 on
selected phenotypes evident at early, mid and late stage of life of
diseasedmice. The selection of phenotypes was based on different
objectives according to the age of the rodent.
As ‘‘early phenotypes’’ we specifically analyzed two events:
the induction of DDR and the expression of Rrs1. mHtt is
associated with DNA damage and its phosphorylation status
is crucial for cellular handling of genomic stress (Anne et al.,
2007). DDR leads to ATM kinase activation followed by
phosphorylation of H2AX at genomic sites of double strand
breaks and consequent stabilization and activation of p53. This
pathway is a hallmark of the disease since H2AX-positive sites
have been found in the striatum of HD human post-mortem
brains and recapitulated in PC12 cells expressing a pathogenic
fragment of mHtt, in HD striatal cell lines (STHdhQ111) and
in the striatum of R6/2 mice (Anne et al., 2007; Illuzzi et al.,
2009). Here we provide evidence that DDR in the striatum
of HdhQ111 knock-in mice is significantly reduced in the
absence of Pin1. In this context a crucial Pin1 target is p53.
We previously showed that in the striatum of 12 month old
HdhQ111 mice the p53 protein is increased and phosphorylated
on Ser46, mimicking p53 status in HD post-mortem brains.
This promotes p53/Pin1 interaction and its transcriptional
activity targeted to p21WAF and PUMA. p53 transcriptional
property is strictly dependent on a functional Pin1 sinceHdhQ111
mice that are knock-out for Pin1 lack p21WAF and PUMA
induction (Grison et al., 2011). Apoptosis induced by mHtt
is mediated at least in part by p53 since it was reduced by
50% upon p53 silencing (Bae et al., 2005). A similar effect
was observed upon silencing of Pin1 in the same experimental
settings. Importantly, neuronal loss observed at 24 months in
Pin1 knock-out mice was not increased in HdhQ111:Pin1KO
mice suggesting that in mice devoid of Pin1 the lack of p53
activation prevents mHtt-dependent neurodegeneration (Grison
et al., 2011).
We also analyzed the effects of Pin1 loss on the
induction of Rrs1. We chose this molecular event since
Rrs1 is a nucleolar protein involved in rRNA biogenesis
and associated to endoplasmic reticulum stress. Both
pathways are altered in several neurodegenerative
diseases suggesting they might play an important role in
FIGURE 4 | Lack of Pin1 reduces astrocytic gliosis in striatum of aged
HdhQ111 mice. (A) Comparison of glial fibrillary acidic protein (GFAP)
immunostaining between striatum of heterozygous HdhQ111 and wild-type
HdhQ7 mice at 24 months of age. Left panels show representative bright-field
images of mouse brain coronal sections (2.5x). The region of the striatum
highlighted in the box is shown in the right panels (10x) after immunostaining
with GFAP antibody. GFAP reactivity indicates reactive astrocytic gliosis in
mutant compared to wild-type striatum. Scale bar, 100 µm.
(B) Representative confocal images of GFAP staining at two different
magnification (10x − 20x) of striatal sections from heterozygous HdhQ111 mice
on wild-type or knock-out Pin1 genetic background. GFAP reactivity reveals
reduced astrocytic gliosis in HdhQ111 mice depleted of Pin1 compared to Pin1
wild type mice. The nuclear staining with 4′,6-diamidino-2-phenylindole (DAPI)
is shown in blue. (Scale bars: panel 10x = 100 µm, panel 20x = 40 µm). (C)
Quantification (arbitrary units) of GFAP fluorescent intensity in striatum of
HdhQ111 mice on wild-type or knock-out Pin1 genetic background. Histogram
bars represent mean ± standard error, three sections per mouse and four
mice per genotype. Data indicate significant reduction of GFAP reactivity in
HdhQ111 mice lacking of Pin1 (∗∗Two tail paired t-test p < 0.01).
neurodegeneration. We previously reported that Rrs1 induction
was evident for the entire first year of life (both ‘‘early’’ and
‘‘intermediate phenotypes’’; Carnemolla et al., 2009). Here
we assess that Pin1 is dispensable for Rrs1 overexpression
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both at 3.5 (Figure 1D) and at 12 months (data not
shown).
In summary these results suggest that Pin1 is involved in some
but not all pathways altered early in HdhQ111 mice.
This observation led us to ask a crucial question: given
that Pin1 participates in selected pathways triggered by
mHtt, may we estimate and identify the fraction of HdhQ111
phenotypes that depend on a functional Pin1? We reasoned
that the best strategy to assess this fundamental feature
was to take advantage of next generation sequencing
technology to carry out an unbiased transcriptome-wide
approach. To study the largest number of pathways in a
single experiment we choose to analyze 12 months old mice
(‘‘intermediate phenotype’’). At this age mHtt can trigger a
large number of alterations in the striatum while events are
still probably far from being at the final irreversible disease
stage.
We thus compared genes and associated biological
terms that are altered in mHtt with those changing in
absence of Pin1. By this approach we obtained two pieces
of information. First, 10% (156/1493) of the biological
terms affected by mHtt are common with those targeted by
deleting Pin1 in HdhQ111 mice. This suggests that Pin1 is
involved in a small portion of mHtt phenotypes. However,
44% (64/145) of the genes and 80% (156/194) of biological
terms associated to loss of Pin1 are contained in the
list of those targeted by mHtt, proving that the majority
of pathways regulated by Pin1 in HdhQ111 mice are
common with those targeted by mHtt in a Pin1 wild-
type background. Half of these genes and biological terms
were also changed in Pin1 knock-out mice with a wild-type Htt
background.
We then showed that loss of Pin1 activity in HdhQ111
mice exerts opposite effects to those triggered by mHtt for
selected pathways and functions. Among them there are
‘‘quantity/synthesis of steroids’’ and ‘‘synthesis/concentration
of hormones’’, two previously known pathways altered in
HD. Concerning hormones, prolactin (PRL) and growth
hormone (GH) have been found down-regulated in the plasma
of HD patients (Markianos et al., 2009; Saleh et al., 2009).
They are part of the hypothalamic-pituitary system that is
targeted in HD affecting food intake and energy balance.
Other genes decreased in HdhQ111 mice include arginine
vasopressin (AVP) and proopiomelanocortin (POMC), a
precursor protein of multiple peptide hormones including
adrenocorticotropic hormone (ACTH) and melanocyte-
stimulating hormone (MSH). While these pathways and
functions are not significantly altered in Pin1 knock-out mice
in a Htt wild-type background, selected genes such as PRL and
GH are among the most differentially expressed genes in this
comparison. Overall, these results may lead to further studies
concerning the still unexplored role of Pin1 as a regulator of
neuropeptides and hormone synthesis/release in health and
diseased conditions.
‘‘Wnt/β-catenin signaling’’, ‘‘PCP pathway’’ and ‘‘Role of
Wnt/GSK-3β signaling in the pathogenesis of influenza’’ are
all changed in mHtt mice (repression) but in opposite
direction when Pin1 is depleted (activation). Several evidences
support the notion that Wnt/β-catenin signaling is altered
in HD although contrasting data and interpretations have
been proposed (Carmichael et al., 2002; Gines et al., 2003;
Godin et al., 2010; Valencia et al., 2010; Dupont et al.,
2012; Lim et al., 2014). In our study Wnt9b, Wnt8b and
Wnt4 levels are all decreased in the striatum of HdhQ111
mice. Furthermore, there is a significant reduction in the
expression of the receptor Fzd10 and of the transcription
factor Lef1. Interestingly, one of the genes induced at the
highest level is Wilms tumor suppressor gene (Wt1), a
well-known regulator of the β-catenin pathway. Pin1 has
been shown to regulate Wnt/β-catenin signaling pathways at
least in two regulatory steps. In neuronal progenitor cells,
Pin1 binds and stabilizes its substrate β-catenin and this
interaction is required for appropriate neuronal differentiation
(Nakamura et al., 2012). In the brain Pin1 also binds
GSK-3β inhibiting its kinase activity and this is believed to
play a fundamental role in promoting APP turnover (Lu
et al., 1999). In the differential gene expression analysis
of Pin1 knock-out mice in a Htt wild-type background all
three pathways related to Wnt signaling were significantly
enriched. Loss of Pin1 might thus interfere with Wnt signaling
pathways at distinct regulatory steps both in wild-type and
HdhQ111 mice.
As ‘‘late phenotypes’’ we focused our attention on the
formation of NIIs and gliosis in HdhQ111 mice that both mimic
neuropathological data in human post-mortem brains. It is
therefore particularly interesting that both of them are modified
by Pin1 loss.
NIIs are produced from the monomeric forms of mHtt
through the generation of various intermediate species.
The diverse toxicity of these structures is however still
controversial and is discussed in several reviews (Hands
and Wyttenbach, 2010; Arrasate and Finkbeiner, 2012). In
brief, it has been suggested that intermediate aggregates are
more toxic than inclusions. In turn these might represent a
protective mechanism to sequester toxic misfolded species of
mHtt that would otherwise impair cellular viability. However,
in the long run, inclusions may become toxic as well, by
disrupting cellular transport or sequestering protective soluble
proteins.
Here we show that loss of Pin1 significantly enhances the
number of NIIs specifically in the striatum of HdhQ111 mice.
The mechanism that promotes the formation of inclusions in
striatal neurons when Pin1 is depleted remains unclear. Pin1
exerts its activity on different substrates in different physiological
and/or pathological conditions while multiple cellular pathways
are involved in the aggregation process of proteins with
an expanded polyglutamine tract. Indeed, conformational
changes and aggregation of mHtt may be modulated by
interacting partners, posttranslational modifications of the
protein, as well as by alteration in the homeostasis of
protein degradation systems such as UPS and autophagy. In
this context, in Parkinson’s disease Pin1 has been shown
to regulate alpha-synuclein aggregation by modifying the
activity of the alpha-synuclein binding partner synphilin
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(Ryo et al., 2006). In Alzheimer’s disease Pin1 participates in
APP processing and neurofibrillary tangle formation (Pastorino
et al., 2006). Importantly, in Hdh knock-in mice we found
the Pin1 effect visible only in striatal cells suggesting a cell-
type specific activity in the very same neurons that undergo
degeneration.
Proliferation of glial cells is a prominent feature of HD
pathology. Reactive astrocytic gliosis is selectively detected in
HD striatum starting from Grade 0 of pathology (Vonsattel
et al., 1985). Several mechanisms could account for the
loss of gliosis in a Pin1 knock-out background. This
phenotype may depend on the established role of Pin1 in
cell proliferation control and therefore be due to a cell
autonomous function of Pin1 in astrocytes. However we
may also speculate that this may be a secondary effect
of Pin1 function in neurons. Therefore, the role of Pin1
in gliosis remains a very interesting topic to be further
investigated.
It is not clear whether Pin1 effects in NIIs formation and
gliosis are the effects of loss of Pin1 activity throughout the
lifespan of the rodent or are the consequence of specific functions
in aging mice. This observation is indeed valid for ‘‘intermediate
phenotypes’’ as well. The use of Pin1 inhibitors in selected
time windows may provide the correct answer to this important
question.
In summary, we have shown that Pin1 participates in a
portion of the processes at the core of HD pathogenesis in
vivo. Further studies will evaluate the impact of these molecular
phenotypes on the behavioral alterations observed in HD mice
models.
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SUPPLEMENTARY FIGURE S1 | Representative confocal images of
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SUPPLEMENTARY TABLE T1 | Differential gene expression in the
striatum of HdhQ111 vs. HdhQ7 (Pin1WT background), Pin1WT vs. Pin1KO
(HdhQ111 background) and Pin1WT vs. Pin1KO (HdhQ7 background)
mice. Significantly differentially expressed gene lists were computed using
EdgeR software (see methods). For each gene table we selected the genes
with adjust p value < 0.001 and log fold change (logFC) higher than 0.7 or
smaller than −0.7. A list of 621 genes (116 increase and 505 decreased) are
identified as significantly altered in HdhQ111 vs. HdhQ7 (Pin1WT background)
and a list of 145 genes (48 increased and 97 decreased) are identified as
differentially regulated in Pin1WT vs. Pin1KO (HdhQ111 background). By
comparing Pin1WT vs. Pin1KO (HdhQ7 background) 213 genes (121 increased
and 92 decreased) are identified as significantly altered.
SUPPLEMENTARY TABLE T2 | Comparison of differentially expressed
gene lists. By comparing the gene lists in Table T1 we obtained seven new
list of genes. The column “n=29 Overlaps” contains the genes that are
common among the three gene lists of Table T1. The column “n=85 Overlaps”
contains the genes that are common between HdhQ111 vs. HdhQ7 (Pin1WT )
and Pin1WT vs. Pin1KO (HdhQ7) lists. The column “n=35 Overlaps” contains the
genes that are common between HdhQ111 vs. HdhQ7 (Pin1WT ) and Pin1WT vs.
Pin1KO (HdhQ111) lists. The column “n=33 Overlaps” contains the genes that
are common between Pin1WT vs. Pin1KO (HdhQ111) and Pin1WT vs. Pin1KO
(HdhQ7). The column “n=472 Specific” contains the genes that are specific for
mHtt. The column “n=48 Specific” contains the genes that are specific for loss
of Pin1 in a mHtt background. The column “n=66 Specific” contains the genes
that are specific for loss of Pin1 in a wild-type Htt background.
SUPPLEMENTARY TABLE T3 | Functional analysis of differentially
expressed genes lists. Differentially expressed gene lists in Table T1 were
analyzed for functional associations with ClusterProfiler. All mouse genes from
“org.Mm.eg.db” package were used as background population. Each table
reports statistical data and the gene list associated with each GO term. GO
terms are based on the Gene Ontology Consortium available at:
http://www.geneontology.org/.
SUPPLEMENTARY TABLE T4 | Comparison of functional analysis lists.
By comparing the functional analysis lists in Table T3 we obtained seven new
lists: 1) “n=75 Overlaps” contains 75 GO terms that are common among the
three lists of Table T3; 2) “n=135 Overlaps” contains 135 GO terms that are
common between HdhQ111 vs. HdhQ7 (Pin1WT ) and Pin1WT vs. Pin1KO (HdhQ7)
lists; 3) “n=81 Overlaps” contains 135 GO terms that are common between
HdhQ111 vs. HdhQ7 (Pin1WT ) and Pin1WT vs. Pin1KO (HdhQ111) lists; 4) “n=3
Overlaps” contains 3 GO terms that are common between Pin1WT vs. Pin1KO
(HdhQ111) and Pin1WT vs. Pin1KO (HdhQ7); 5) “n=1202 Specific” contains
contains 1202 GO terms specific for HdhQ111 vs. HdhQ7 (Pin1WT ); 6) “n=35
Specific” contains 35 GO terms specific for Pin1WT vs. Pin1KO (HdhQ111); 7)
“n=29 Specific” contains 29 GO terms specific for Pin1WT vs. Pin1KO (HdhQ7).
SUPPLEMENTARY TABLE T5 | Activation and repression of biological
terms with Ingenuity Pathway Analysis. This table shows the predicted
activation and repression of different biological terms obtained from Table T1
using IPA. For each table, the gene list associated to each pathway or function
is reported.
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